Tilray Brands, Inc.
TLRY · Price history
Price at last available close
$2.77
−$1.25 (-31.09%) 1M
2026-10-27
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Tilray Brands, Inc.
Primary reporting period: 2026-05-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness.
How they make money
Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company. It generates revenue through the production, distribution, and sale of cannabis products, craft beverages, and wellness products across international markets, leveraging a diversified house of brands to reach consumers and medical patients.
Products & services
The company provides medical and adult-use cannabis, craft beer and spirits, and hemp-based food products. Its offerings include cannabis flower, oils, and extracts, as well as a portfolio of craft beverage brands and wellness-focused consumer goods.
Brands & revenue mix
Global medical cannabis brand for prescribers and patients.
Separate brand revenue is not available in this research.Source
Canadian medical cannabis brand.
Separate brand revenue is not available in this research.Source
Small-batch medical cannabis brand.
Separate brand revenue is not available in this research.Source
Canadian medical cannabis brand focused on variety and price.
Separate brand revenue is not available in this research.Source
Cannabis brand known for reliable flower products.
Separate brand revenue is not available in this research.Source
Cannabis brand with a legacy of cultivation.
Separate brand revenue is not available in this research.Source
Premium German-grown cannabis brand.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
Period ended 2026-05-31Source
Period ended 2026-05-31Source
Period ended 2026-05-31Source
Period ended 2026-05-31Source
Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.
Customer concentration
No quantified customer-concentration disclosure is available in the current saved research.
Suppliers, materials & equipment
- Unnamed — Pharmaceutical distributors for the distribution of medical cannabis products.Source
Strengths
Sources
Financial risk observations and what to check
These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-08-31.
Diluted weighted-average shares increased 25.8% year over year.
Compare per-share results with total earnings and inspect the equity footnote. A change in weighted-average shares does not by itself establish the cause, the number of shares issued today, or the economic effect of a split.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
25
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
30
Poor
Financial Strength
56
Business Quality / Moat
36
Management
0
Growth Quality
28
Risk / Durability
4
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
45
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
50/100
Building Historical Record
Model Score 50/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Balance-sheet / debt profile scores strongly
- •Insider activity signal is favorable
- •Recent buyback activity is present
- •Debt service risk
- •M&A headline · Oct 13, 2026
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
Company-specific research
Questions worth answering for TLRY
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can TLRY maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •How long can TLRY fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •Does TLRY's balance between cash and debt leave enough flexibility if business conditions weaken?
- •What specifically needs to improve for TLRY to reach sustainable profitability?
- •What future growth or profitability would be needed to justify TLRY's current valuation?
Essential Investment Snapshot
Wall Street Score
25
Opportunity Score
45
Market Cap
$309.8M
P/E Ratio
-2.1
EPS
$-1.40
52-Week High
$15.70
52-Week Low
$2.88
Beta
1.92
Analyst Target
$41.50
Shares Outstanding
111.8M
Total Revenue
$963.1M
Total Debt
$371.9M
Dividend
No current dividend
Liquidation Value / Share
$14.37
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong downward momentum
Normal movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for TLRY
Detected from reported data — verify before acting.Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Debt service risk
Interest coverage is low (~-2.1x). Earnings may be strained to cover interest expense.
M&A headline · Oct 13, 2026
BrewDog Acquisition Boosts Tilray's Q1 Performance — This is a provider-linked headline, not an independently confirmed event. Check the article and company filings for the subject, proposed/completed status, and subsequent updates.
Seeking AlphaCommunity Sentiment
0 active · 0 total callsNo personal call yet on TLRY.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Global EU-GMP certified production facilities.
- +Diversified house of over 40 brands.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Drug Manufacturers - Specialty & Generic industry.
- −Regulatory and legal risks associated with cannabis cultivation and sale.
- −Cybersecurity and information technology risks.
- −Diluted weighted-average shares increased 25.8% year over year.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
5 historical score records availablePrevious Score
26
Oct 9, 2026
Change
-1.3
points
Current Score
25
Oct 22, 2026
Category Changes
TLRY decreased 1.3 points because Revenue declined by 12.4 points, Buffett declined by 2.5 points.
Negative Contributors
- − Revenue declined by 12.4 points
- − Buffett declined by 2.5 points
Projected Score
Projected Score
29
Projected Change
+4.0 points
Preliminary comparable-period financial changes suggest improvement of approximately 4.0 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$2.77
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $963.1M | $915.5M | $821.3M | $1.07B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $688.8M | $655.0M | $580.7M | $770.7M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $274.3M | $260.4M | $240.6M | $304.3M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $409K | $361K | $284K | $865K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $318.1M | $295.2M | $260.4M | $341.6M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $351.5M | $323.5M | $2.52B | $542.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | -$18.5M | $9.5M | -$2.13B | -$99.3M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | -$77.2M | -$63.0M | -$2.28B | -$238.1M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $23.4M | $29.9M | $41.3M | $67.1M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | -$125.6M | -$88.1M | -$2.30B | -$339.3M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $21.1M | $17.1M | -$121.0M | -$36.3M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | -$164.2M | -$122.6M | -$2.19B | -$333.8M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $-1.40 | $-1.09 | $-24.56 | $-4.50 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 133M | 112M | 89.03M | 74.26M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 133M | 112M | 89.03M | 74.26M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$257.1M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$0.32
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-16.4%
Cash Change
-40.9%
Margin Change
-16.6 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Debt reduced
What Weakened
- Margins contracted
- Cash position declined
Potential Score Impact
Positive indicators included revenue growth, EPS growth, debt levels. Pressure indicators included cash levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 22.7%. EPS increased 7900.0%. Cash declined 40.9%. Total debt declined 16.4%. Net income margin declined by 16.6 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
5 historical recordsHistorical Score Chart
3 of 5 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Drug Manufacturers - Specialty & GenericNews
Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out?
Blue Point Brewing Co.'s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews
West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers
Tilray Brands (TSE:TLRY) Sets New 52-Week Low – Here’s Why
Rumor Mill · TLRY
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial